The Importance of Proactively Addressing and De-labeling Antibiotic Allergy (AAN)
Price: FREE for members and non-members
Session recorded on January 29, 2024
Speaker: Kimberly Blumenthal, MD, MSC
With the rise of drug-resistant organisms, proactive evaluation and delabeling of inaccurate antibiotic allergies is a key component of antibiotics stewardship and quality improvement. Unverified penicillin allergies can have adverse consequences for public health and individual health. The goal of proactive penicillin allergy evaluations is to remove the label if the allergy is found to be untrue.
Viewers can earn credit by completing the post-test questions.
This program is a collaboration between the American College of Allergy, Asthma & Immunology and the Allergy and Asthma Network (AAN).
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Primary Care Providers
Allied Health Professionals
At the conclusion of this activty, learners should be able to:
1. Describe the importance of proactive penicillin allergy evaluations and delabeling.
2. Explain how to perform a penicillin allergy evaluation.
3. Identify the populations most at risk of an unverified penicillin allergy label.
All identified relevant financial relationships with ineligible companies have been mitigated.
Kimberly Blumenthal, MD, MSC, Speaker
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance